Incretin-based therapy and risk of cholangiocarcinoma: a nested case–control study in a population of subjects with type 2 diabetes

Background and aims One cohort and several basic science studies have raised suspicion about an association between incretin therapies and cholangiocarcinoma. Our aim was to verify the occurrence of CC in relation to incretin-based medication use versus any antidiabetic treatment in an unselected po...

Full description

Saved in:

Bibliographic Details
Published in:	Acta diabetologica Vol. 57; no. 4; pp. 401 - 408
Main Authors:	Giorda, Carlo B., Picariello, Roberta, Tartaglino, Barbara, Nada, Elisa, Costa, Giuseppe, Gnavi, Roberto
Format:	Journal Article
Language:	English
Published:	Milan Springer Milan 01.04.2020 Springer Nature B.V
Subjects:	Antidiabetics Cholangiocarcinoma Diabetes Diabetes mellitus (non-insulin dependent) GLP-1 receptor agonists Internal Medicine Medicine Medicine & Public Health Metabolic Diseases Original Article Patients Population Population studies Risk factors Safety in diabetes treatment Administrative data Incretin-based medications Case–control study Cholangiocarcinoma
ISSN:	0940-5429, 1432-5233, 1432-5233
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!